Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma-Reference-Cited by-同舟云学术

Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma

Published:2019-09-09 Issue:10 Volume:129 Page:4377-4392
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Bayles Ian,Krajewska Malgorzata,Pontius W. Dean^ORCID,Saiakhova Alina,Morrow James J.,Bartels Cynthia,Lu Jim,Faber Zachary J.^ORCID,Fedorov Yuriy,Hong Ellen S.,Karnuta Jaret M.^ORCID,Rubin Brian,Adams Drew J.,George Rani E.^ORCID,Scacheri Peter C.

Funder

National Institutes of Health

National Cancer Institute

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/127718/files/pdf

Reference55 articles.

1. Tumor Metastasis: Molecular Insights and Evolving Paradigms

2. Osteosarcoma incidence and survival rates from 1973 to 2004

3. Outcome for Children with Metastatic Solid Tumors over the Last Four Decades

4. Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

5. Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK12 is a promising therapeutic target for the transcription cycle and DNA damage response in metastatic osteosarcoma;Carcinogenesis;2024-07-31

2. CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer;Scientific Reports;2024-03-19

3. Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis;Nature Communications;2023-11-08

4. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach;Clinical Cancer Research;2023-09-13

5. CDK12/CDK13 inhibition disrupts a transcriptional program critical for glioblastoma survival;2023-07-17